参考文献/References:
[1] Szpalski MGunzburg R.Lumbar spinal stenosis in the elderly,an overview[J].Eur Spine J,2003,12:S17,1-5.
[2] 何元诚.退变性腰椎管狭窄症的中医药治疗进展[J].广西中医学院学报,2007,10(4):92-94.
[3] 李金学,曹勇,赵敏.中西药物优化组合治疗退行性腰椎管狭窄症的疗效观察[J].中国中医骨伤科杂志,2007,15(12):21-24.
[4] 李金学,朱立国,罗杰.腰痹颗粒治疗退行性腰椎管狭窄症的疗效观察[J].世界中医药,2013,8(11):1305-1308.
[5] 黄继汉,黄晓晖,陈志扬,等.药理实验中动物间和动物与人体间的等效剂量换算[J].中国临床药理学与治疗学,2004,9(9):1069-1072.
[6] Wootla B,Denic A,Watzlawik JO,et al. A single dose of a neuron binding human monoclonal antibody improves brainstem NAA concentrations,a biomarker for density of spinal cord axons,in a model of progressive multiple sclerosis[J].Neuroinflammation,2015,12:83.
[7] 周磊,李明,刘培来,等.椎板切除碎骨粒回植法制作腰椎管狭窄动物模型[J].中国临床解剖学杂志,2007,25(6):660-664.
[8] Iwamoto H,Matsuda H,Noriage A,et al.Lumbar spinal canal stenosis examined electrophysiologically in a rat model of chronic cauda equina COMP ression[J].Spine,1997,22(22):2636-2640.
[9] 龚炎培,高井宏明.腰椎管狭窄动物模型的实验研究[J].南通医学院学报,2003,23(4):412-413.
[10] 高松,刘海鹰,钱亚龙.腰椎管狭窄症动物模型研究进展[J].中国脊柱脊髓杂志,2010,20(1):66-68.
[11] 梁益建,孙普全,汪克建,等.大鼠脊髓慢性压迫性损伤实验模型的建立[J].中国临床解剖学杂志,2006,24(3):320-340.
[12] 贾连顺,杨立利.退变性腰椎管狭窄症的现代外科学概念[J].中华骨科杂志,2002,22(8):509-512.
[13] 周磊,李明,刘培来,等.椎板切除碎骨粒回植法制作腰椎管狭窄动物模型[J].中国临床解剖学杂志,2007,25(6):660-664.
[14] 杨仁轩,陈志强,郭庆斌,等.1 335例腰椎管狭窄症住院患者中西医结合诊治疗效观察[J].新中医,2012,44(5):44-46.
[15] 温欣,周洪雷.鳖甲化学成分和药理药效研究进展[J].西北药学杂志,2008,23(2):122-123.
[16] Lee JH,Choi CB,Chung DJ,et al.Development of an im-proved canine model of percutaneous spinal cord compres-sion injury by balloon catheter[J].J Neurosci Methods,2008,167(2):310-316.
[17] 白伦浩,王瑜,张田鹏.骨性关节炎生物学标记物软骨寡聚基质蛋白的研究进展[J].中国修复重建外科杂志,2010,24(6):714-717.
[18] Gagarina V,Carlberg AL,Pereira-Mouries L,et al.Cartilage oligomeric matrix protein protects cells against death by elevating members of the IAP family of survival proteins[J].J Biol Chem,2008,283(1):648-659.
[19] Wisowska M,Jabońska B.Serum cartilage oligomeric matrix protein(COMP)in rheumatoid arthritis and knee osteoarthritis[J].Clin Rheu-matol,2005,24(3):278-284.
[20] Larsson E,Erlandsson Harris H,Larsson A,et al.Corticosteroidtreatment of experimental arthritis retards cartilage destruction asdetermined by histology and serum COMP[J].Rheumatology(Ox-ford),2004,43(4):428-434.
[21] 朱台航,蔡春元,张雷.骨关节炎生物标记物COMP的研究进展[J].中国骨伤,2010,23(12):959-961.
[22] Honore P,Luger NM,Sabino MA,et al.Osteoprotegerin blocks bone cancer-induced skeletal destruction,skeletal pain and pain-related neurochemical reorganization of the spinal cord[J].Nat Med,2000,6(5):521-528.
[23] Omair A,Holden M,Lie BA,et al.Treatment outcome of chronic low back pain and radiographic lumbar disc degeneration are associated with inflammatory and matrix degrading gene variants:a prospective genetic association study[J].BMC Musculoskelet Disord,2013,14:105-109.
[24] 陈海,龚凯,罗卓荆.等.退变性腰椎管狭窄中小关节源性炎性因子作用的初步探讨[J].中国矫形外科杂志,2010,18(7):148-151.
[25] 任炳旭,马正良,靳艳卿,等.身痛逐瘀汤对骨癌痛小鼠痛行为及脊髓星形胶质细胞活化的影响[J].中国中西医结合杂志,2011,10(1):381-385.
[26] Pelletier JP,Martel-Pelletier J,Abramson SB.Osteoarthritis,an inflammatory disease:potential implication for this selection of new therapeutic targets[J].Arthritis Rheum,2001,44:1237-1247.
[27] 吴德升,张琰,孟阳.腰椎管内静脉血清中炎性因子与腰椎管狭窄的关系[J].中国组织工程研究,2014,18(26):4229-4235.
[28] Wisowska M,Jabońska B.Serum cartilage oligomeric matrix protein(COMP)in rheumatoid arthritis and knee osteoarthritis[J].Clin Rheu-matol,2005,24(3):278-284.
[29] Jimbo K,Park JS,Yokosuka K,et al.Positive feedback loop of interleukin-1 beta upregulating production of inflammatory mediators in human intervertebral disc cells in vitro[J].J Neurosurg Spine,2005,2(5):589-595.